Table 3.
Treatments1 | Dose, µg/g | DMD, % | NDFD, % | ADFD, % | ||||||
---|---|---|---|---|---|---|---|---|---|---|
12 h | 24 h | 48 h | 12 h | 24 h | 48 h | 12 h | 24 h | 48 h | ||
Control | 0 | 19.5 | 31.5 | 40.7 | 10.0 | 24.7 | 35.5 | 7.4 | 21.9 | 32.5 |
Viscozyme L | 100 | 20.8 | 33.0 | 41.2 | 10.9 | 26.0 | 35.6 | 5.9 | 23.9 | 33.2 |
500 | 20.7 | 33.6 | 41.5 | 11.2 | 26.6 | 36.2 | 8.6 | 22.9 | 34.3 | |
EGL7A | 100 | 21.2 | 33.6 | 41.3 | 11.9 | 26.8 | 36.1 | 7.4 | 24.1 | 33.3 |
500 | 20.7 | 33.8 | 40.6 | 10.8 | 26.8 | 35.4 | 7.6 | 23.8 | 33.6 | |
XYL10A | 100 | 20.8 | 32.9 | 42.1 | 10.9 | 25.9 | 37.2 | 7.8 | 23.4 | 34.4 |
500 | 21.1 | 31.7 | 42.3 | 10.9 | 24.5 | 37.0 | 4.9 | 21.4 | 35.4 | |
XYL10C | 100 | 20.4 | 33.2 | 42.7 | 10.5 | 26.3 | 37.7 | 5.9 | 24.1 | 35.5 |
500 | 21.3 | 32.8 | 44.0 | 11.6 | 25.7 | 38.9 | 6.6 | 22.4 | 36.4 | |
Enzyme mixture | 100 | 21.2 | 34.0 | 41.7 | 11.0 | 27.2 | 36.0 | 5.7 | 24.7 | 33.1 |
500 | 20.7 | 32.8 | 43.6 | 10.9 | 25.8 | 38.9 | 8.7 | 22.5 | 35.6 | |
SEM | 1.22 | 1.51 | 1.47 | |||||||
Contrasts P-value2 | ||||||||||
Con vs. Enz | <0.001 | 0.008 | 0.08 | |||||||
Con vs. Enz 100 | 0.002 | 0.01 | 0.12 | |||||||
Con vs. Enz 500 | 0.001 | 0.01 | 0.07 | |||||||
Enz 100 vs. Enz 500 | 0.73 | 0.82 | 0.69 | |||||||
Con vs. Viscozyme L | 0.02 | 0.08 | 0.18 | |||||||
Con vs. EGL7A | 0.01 | 0.03 | 0.12 | |||||||
Con vs. XYL10A | 0.01 | 0.09 | 0.35 | |||||||
Con vs. XYL10C | <0.001 | 0.003 | 0.06 | |||||||
Con vs. enzyme mixture | <0.001 | 0.007 | 0.08 |
1Viscozyme L (Novozymes Inc., Copenhagen, Denmark) = commercial crude enzyme preparation from Aspergillus aculeatus; EGL7A = endo-β-1,4-glucanase, EC 3.2.1.4, GH7 from Thielavia terrestris; XYL10A = 1,4-β-xylanase, EC 3.2.1.8, GH10 from Rasamsonia emersonii; XYL10C = 1,4-β-xylanase, EC 3.2.1.8, GH10 from Aspergillus niger; enzyme mixture = 20:20:20:20:20 mix of EGL7A, XYL10A, XYL10C, AXH62A (arabinoxylan arabinofuranosidase, EC 3.2.1.55, GH62 from Myceliophthora thermophile), and AXE1A (acetylxylan esterase, EC 3.1.1.72, CE1 from M. thermophile).
2Con = control treatment; Enz = all enzyme treatments; Enz 100 = enzyme treatments with 100 µg of protein load per gram of substrate DM; Enz 500 = enzyme treatments with 500 µg of protein load per gram of substrate DM.